Mackay, H., Nixon, A. B., Enserro, D., Bender, D., Rimel, B. J., Powell, M. A., … Swisher, E. M. (2023). Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Mackay, Helen, Andrew B. Nixon, Danielle Enserro, David Bender, B. J. Rimel, Matthew A. Powell, Debra L. Richardson, et al. “Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Mackay H, Nixon AB, Enserro D, Bender D, Rimel BJ, Powell MA, et al. Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Mackay, Helen, et al. “Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Mackay H, Nixon AB, Enserro D, Bender D, Rimel BJ, Powell MA, Richardson DL, Holman LL, Alluri N, Mathews CA, Garg R, Gill S, Matei D, Leath CA, Backes FJ, Fleury A, Swisher EM. Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012. JOURNAL OF CLINICAL ONCOLOGY. 2023.